Evidence
N Z Med J. 2024 May 3;137(1594):23-30. doi: 10.26635/6965.6392.
ABSTRACT
AIM: To report dispensing trends for attention-deficit hyperactivity disorder (ADHD) in Aotearoa New Zealand, focussing on adults in order to highlight increasing demand for ADHD treatment by adults and to prompt discussion.
METHOD: Demographic and dispensing data for ADHD were obtained from the Pharmaceutical Collection between the years 2006 and 2022. This was stratified according to child (<18 years) and adult (≥18 years) populations. Population dispensing rates for methylphenidate and atomoxetine were calculated. Key findings are reported to reveal demographic and dispensing trends for medication treated ADHD in Aotearoa New Zealand.
RESULTS: More males are dispensed ADHD medication than females, although this is less evident for adults (54.8% male). Māori adults are dispensed ADHD medication at a lower rate (10.1%) than Māori children (22.9%). There was a 10-fold increase in dispensing of ADHD medication for adults compared to a three-fold increase for children over the study period. New dispensing for adults doubled between 2011 and 2022.
CONCLUSION: Medication treatment for adult ADHD is increasing in Aotearoa New Zealand and includes treatment for persisting childhood ADHD and new diagnoses made in adulthood. Despite increases, dispensing rates for ADHD remain lower than prevalence estimates, suggesting a significant treatment gap. Addressing the treatment gap for ADHD may reduce negative effects of ADHD, but wider social influences should also be considered.
PMID:38696829 | DOI:10.26635/6965.6392
Add to Google Keep
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Dispensing of attention-deficit hyperactivity disorder medications for adults in Aotearoa New Zealand
🌐 90 Days
VR Related Evidence Matrix
- Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea
- What is adult ADHD after all?
- Attention-Deficit/Hyperactivity Disorder Medications and Work Disability and Mental Health Outcomes
- Childhood attention-deficit hyperactivity disorder: socioeconomic inequalities in symptoms, impact, diagnosis and medication
- Paraphilic fantasies and behavior in attention deficit/hyperactivity disorder and their association with hypersexuality
- Changes in real-world dispensing of ADHD stimulants in youth from 2019 to 2021 in California
- Exposure to digital vape marketing among young people in Aotearoa New Zealand
- Associations between attention-deficit hyperactivity disorder genetic liability and ICD-10 medical conditions in adults: utilizing electronic health records in a Phenome-Wide Association Study
- Attention deficit disorder with/without hyperactivity and obesity in adolescence
- Maternal diabetes and risk of attention-deficit/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother-child pairs
- Effect of biofeedback intervention on neurological characteristics of children with attention deficit hyperactivity disorder
- The role of personal strengths in the relationship between adult attention-deficit/hyperactivity symptoms and perceived stress
- Attention-Deficit Hyperactivity Disorder (ADHD) Medication Use Trajectories Among Women in the Perinatal Period
- Non-pharmacological treatment of Attention Deficit Disorder with or without Hyperactivity (ADHD). Overview and report of the first international symposium on the non-pharmacological management of ADHD
- Longitudinal Patterns of Community-Based Treatment Utilization Among Ethnically and Racially Diverse Adolescents with Attention-Deficit/Hyperactivity Disorder
- Correlations between developmental trajectories of brain functional connectivity, neurocognitive functions, and clinical symptoms in patients with attention-deficit hyperactivity disorder
- Correlations between developmental trajectories of brain functional connectivity, neurocognitive functions, and clinical symptoms in patients with attention-deficit hyperactivity disorder
- Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorder
- Prevalence of Enuresis in Children, Adolescents, and Young Adults Diagnosed With Attention Deficit Hyperactivity Disorder
- Armodafinil as a Potential Pharmacological Treatment for Attention Deficit Hyperactivity Disorder in Adults: A Review
- Novel pharmacological targets for GABAergic dysfunction in ADHD
- Body Mass Index Changes in Children and Adolescents Treated with Methylphenidate for Attention Deficit Hyperactivity Disorder
- Body Mass Index Changes in Children and Adolescents Treated with Methylphenidate for Attention Deficit Hyperactivity Disorder
- Prevalence and clinical phenotypes of adult patients with attention deficit hyperactivity disorder and comorbid behavioral addictions
- Alternative routine for reporting chiral amphetamine test results in assessment of attention-deficit/hyperactivity disorder medication: experiences from 2013 to 2023
- Quantifying alcohol-attributable disability-adjusted life years to others than the drinker in Aotearoa/New Zealand: A modelling study based on administrative data
- Is camouflaging unique for autism? A comparison of camouflaging between adults with autism and ADHD
- Empirically derived symptom profiles in adults with attention-Deficit/hyperactivity disorder: An unsupervised machine learning approach
- Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents
- Adult ADHD and pathological narcissism: A retrospective-analysis
- Prediction of internalizing and externalizing symptoms in late childhood from attention-deficit/hyperactivity disorder symptoms in early childhood
- Attention-deficit hyperactivity disorder in adults with epilepsy: An indirect relationship with suicide risk
- Prevalence of adult attention deficit hyperactivity disorder (ADHD) among medical students in the Eastern Province of Saudi Arabia
- Reducing symptoms of attention deficit/hyperactivity disorder (ADHD) in elementary students: the effectiveness of neurofeedback
- Prevalence of attention-deficit hyperactivity disorder in adult prisoners: An updated meta-analysis
- Rhinorrhea and watery eyes in infancy and risk of attention-deficit hyperactivity disorder in school-age children
- Substance use disorders in adults with attention-deficit/hyperactivity disorder: The role of affective temperament
- Relationships of gaming disorder, ADHD, and academic performance in university students: A mediation analysis
- Prevalence of somatic diseases in adults with attention deficit hyperactivity disorder in Japan is highest in people aged ≥40 years with mental disorders: a cross-sectional study of a Japanese health insurance claims database
- Cross-modal conflict deficit in children with attention-deficit/hyperactivity disorder
- Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder
- Autism and attention-deficit/hyperactivity disorder in children with Dravet syndrome: A population-based study
- Determining cutoff scores on the Conners' adult ADHD rating scales that can definitively rule out the presence of ADHD in a clinical sample
- Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults
- Unpacking the overlap between Autism and ADHD in adults: A multi-method approach
- Do maternal anxiety and depressive symptoms predict anxiety in children with and without ADHD at 8 years?
- Exercise Dependency and Overuse Injuries in Attention Deficit Hyperactivity Disorder
- Incidence of ADHD medication use among Finnish children and adolescents in 2008-2019: a need for practice changes?
- Maternal asthma and asthma exacerbation during pregnancy and attention-deficit/hyperactivity disorder in offspring: a population-based cohort study
- Sleep, Alcohol and Cannabis Use in College Students With and Without Attention-Deficit/Hyperactivity Disorder
- Motor proficiency of persons with attention deficit hyperactivity disorder or autism spectrum disorder diagnosed in adulthood
- Attention-deficit/hyperactivity disorder
- Alternative Treatments to Pharmacological Therapy in Pediatric Populations With Attention-Deficit/Hyperactivity Disorder (ADHD): A Scoping Review
- Alternative Treatments to Pharmacological Therapy in Pediatric Populations With Attention-Deficit/Hyperactivity Disorder (ADHD): A Scoping Review
- Motor proficiency of persons with attention deficit hyperactivity disorder or autism spectrum disorder diagnosed in adulthood
- From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care
- Switch to Lisdexamfetamine in the Treatment of Attention-Deficit Disorder at a Psychiatric Outpatient Clinic for School-Aged Children: A Danish Cohort Study
- The Associations Between Sleep and Externalizing and Internalizing Problems in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Empirical Findings, Clinical Implications, and Future Research Directions
- Identifying Risk Factors for Attention-Deficit/Hyperactivity Disorder (ADHD): a Public Health Concern and Opportunity
- Increased risk of attention-deficit/hyperactivity disorder in adolescents with high salivary levels of copper, manganese, and zinc
- Relationship between Traumatic Experiences, Circadian Preference and ADHD Symptoms in Adolescents with ADHD Residing in Institutional Care: A Controlled Study
- Attention deficit hyperactivity disorder, self-esteem and the impact of treatments
- Attention-deficit/hyperactivity disorder and dopamine receptor D4 (DRD4) exon 3 variable number of tandem repeats (VNTR) 2-repeat allele
- The socioeconomic burden of adult attention-deficit/hyperactivity disorder in Spain
Evidence Blueprint
Dispensing of attention-deficit hyperactivity disorder medications for adults in Aotearoa New Zealand
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Dispensing of attention-deficit hyperactivity disorder medications for adults in Aotearoa New Zealand
🌐 365 Days
VR Related Evidence Matrix
- Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea
- Impact of COVID-19 pandemic on prescription stimulant use among children and youth: a population-based study
- What is adult ADHD after all?
- Drug utilisation in children and adolescents before and after the start of the COVID-19 pandemic: Interrupted time-series analyses in three European countries
- Attention-Deficit/Hyperactivity Disorder Medications and Work Disability and Mental Health Outcomes
- Childhood attention-deficit hyperactivity disorder: socioeconomic inequalities in symptoms, impact, diagnosis and medication
- Paraphilic fantasies and behavior in attention deficit/hyperactivity disorder and their association with hypersexuality
- Are We Measuring ADHD or Anxiety? Examining the Factor Structure and Discriminant Validity of the Adult ADHD Self-Report Scale in an Adult Anxiety Disorder Population
- Changes in real-world dispensing of ADHD stimulants in youth from 2019 to 2021 in California
- Descriptive analysis of poisoning cases involving attention deficit hyperactivity disorder medications in Hong Kong
- Attention-deficit hyperactivity disorder medication use is associated with testosterone hypofunction-results from a national claims database analysis
- Reducing Risk in the Treatment of Attention-Deficit/Hyperactivity Disorder Among Adults With Comorbidities
- Attention Deficit Hyperactivity Disorder (ADHD) Causes and Diagnosis in Adults: A Review
- The Paradoxical Clinical Course of Persons with Gambling Disorder and Comorbid Attention-Deficit/Hyperactivity Disorder (ADHD)
- An adolescent boy with kleptomania and attention-deficit hyperactivity disorder treated with methylphenidate and guanfacine: A case report
- Exposure to digital vape marketing among young people in Aotearoa New Zealand
- Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician
- Epidemiology of mental health comorbidity in patients with atopic dermatitis: An analysis of global trends from 1998 to 2022
- Prevalence of Undiagnosed Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in the Young Adult Population of the United Arab Emirates: A National Cross-Sectional Study
- Associations between attention-deficit hyperactivity disorder genetic liability and ICD-10 medical conditions in adults: utilizing electronic health records in a Phenome-Wide Association Study
- Retrospective observational study on the impact of the Covid-19 pandemic on the prescription of medications for the treatment of Attention Deficit/Hyperactivity Disorder. Comparison of a European and an American cohort
- Attention deficit disorder with/without hyperactivity and obesity in adolescence
- Dispensing of psychotropic medications to Australian children and adolescents before and during the COVID-19 pandemic, 2013-2021: a retrospective cohort study
- Screening for Attention Deficit Hyperactivity Disorder in Young Autistic Adults: The Diagnostic Accuracy of Three Commonly Used Questionnaires
- Evaluation and Management of Attention-Deficit/ Hyperactivity Disorder (ADHD) in Children and Adolescents
- Substance Use Disorder in Adults with ADHD in South Dakota
- Assessing aetiological overlap between child and adult attention-deficit hyperactivity disorder symptoms in an extended family design
- Prescription Stimulant Use During Pregnancy and Risk of Neurodevelopmental Disorders in Children
- Practical clinical guidelines and pharmacological treatment for attention-deficit hyperactivity disorder in Asia
- Maternal diabetes and risk of attention-deficit/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother-child pairs
- Effect of biofeedback intervention on neurological characteristics of children with attention deficit hyperactivity disorder
- Prospective Association Between the Dispensing of Antidepressants and of Medications to Treat Osteoporosis in Older Age
- Attention-Deficit Hyperactivity Disorder Status Moderates Polysubstance Use Among Substance Using Populations: A Cross-Sectional Analysis
- The role of personal strengths in the relationship between adult attention-deficit/hyperactivity symptoms and perceived stress
- A scientifically grounded pharmacological treatment of ADHD
- Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases
- Attention-Deficit Hyperactivity Disorder (ADHD) Medication Use Trajectories Among Women in the Perinatal Period
- Who really hoards? Hoarding symptoms in adults with attention-deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD) and healthy controls
- Non-pharmacological treatment of Attention Deficit Disorder with or without Hyperactivity (ADHD). Overview and report of the first international symposium on the non-pharmacological management of ADHD
- Long-term efficacy of a new 6-session cognitive behavioral therapy for adults with attention-deficit/hyperactivity disorder: A randomized, controlled clinical trial
- Sleep in Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder
- Impact of the COVID-19 pandemic on antidepressant and antipsychotic use among children and adolescents: a population-based study
- Risk factors of suicidal spectrum behaviors in adults and adolescents with attention-deficit / hyperactivity disorder - a systematic review
- Longitudinal Patterns of Community-Based Treatment Utilization Among Ethnically and Racially Diverse Adolescents with Attention-Deficit/Hyperactivity Disorder
- Functional reorganization of brain activity in children with attention-deficit/hyperactivity disorder: Evidence from the modulatory effect of cognitive demand during visuospatial attention task
- Correlations between developmental trajectories of brain functional connectivity, neurocognitive functions, and clinical symptoms in patients with attention-deficit hyperactivity disorder
- Correlations between developmental trajectories of brain functional connectivity, neurocognitive functions, and clinical symptoms in patients with attention-deficit hyperactivity disorder
- Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorder
- Early and repeated screening detects children with persistent attention-deficit/hyperactivity disorder
- Prevalence of Enuresis in Children, Adolescents, and Young Adults Diagnosed With Attention Deficit Hyperactivity Disorder
- Exploring the Link Between Attention-Deficit Hyperactivity Disorder and Cannabis Use Disorders: A Review
- Armodafinil as a Potential Pharmacological Treatment for Attention Deficit Hyperactivity Disorder in Adults: A Review
- Novel pharmacological targets for GABAergic dysfunction in ADHD
- Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole
- Language Skills in Children with Attention Deficit Hyperactivity Disorder and Developmental Language Disorder: A Systematic Review
- Body Mass Index Changes in Children and Adolescents Treated with Methylphenidate for Attention Deficit Hyperactivity Disorder
- Body Mass Index Changes in Children and Adolescents Treated with Methylphenidate for Attention Deficit Hyperactivity Disorder
- Prevalence and clinical phenotypes of adult patients with attention deficit hyperactivity disorder and comorbid behavioral addictions
- ADHD, chronotype, and circadian preference in a multi-site sample of college students
- Alternative routine for reporting chiral amphetamine test results in assessment of attention-deficit/hyperactivity disorder medication: experiences from 2013 to 2023
- Quantifying alcohol-attributable disability-adjusted life years to others than the drinker in Aotearoa/New Zealand: A modelling study based on administrative data
- Labour market integration among young adults diagnosed with attention-deficit/hyperactivity disorder (ADHD) at working age
- Is camouflaging unique for autism? A comparison of camouflaging between adults with autism and ADHD
- Empirically derived symptom profiles in adults with attention-Deficit/hyperactivity disorder: An unsupervised machine learning approach